Compare Nasdaq Inc (NDAQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Nasdaq Inc trades at $94.99 (market cap $53.11B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Nasdaq Inc pays the higher dividend (1.22%). Which is the better fit depends on your goals.
| NDAQ | REGN | |
|---|---|---|
Market Cap | $53.11B | $82.06B |
Sector | Financials | Health |
52-Week High | $100.98 | $812.27 |
52-Week Low | $76.85 | $555.51 |
Enterprise Value | $59.57B | $76.77B |
Dividend Yield | 1.22% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
